Ibersol, S.G.P.S., S.A.
Ibersol, S.G.P.S., S.A. Fundamental Analysis
Ibersol, S.G.P.S., S.A. (IBS.LS) shows moderate financial fundamentals with a PE ratio of 25.37, profit margin of 2.56%, and ROE of 4.10%. The company generates $0.7B in annual revenue with strong year-over-year growth of 13.42%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 39.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze IBS.LS's fundamental strength across five key dimensions:
Efficiency Score
WeakIBS.LS struggles to generate sufficient returns from assets.
Valuation Score
ModerateIBS.LS shows balanced valuation metrics.
Growth Score
ModerateIBS.LS shows steady but slowing expansion.
Financial Health Score
ExcellentIBS.LS maintains a strong and stable balance sheet.
Profitability Score
WeakIBS.LS struggles to sustain strong margins.
Key Financial Metrics
Is IBS.LS Expensive or Cheap?
P/E Ratio
IBS.LS trades at 25.37 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, IBS.LS's PEG of 0.42 indicates potential undervaluation.
Price to Book
The market values Ibersol, S.G.P.S., S.A. at 1.07 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 2.28 times EBITDA. This is generally considered low.
How Well Does IBS.LS Make Money?
Net Profit Margin
For every $100 in sales, Ibersol, S.G.P.S., S.A. keeps $2.56 as profit after all expenses.
Operating Margin
Core operations generate 4.67 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $4.10 in profit for every $100 of shareholder equity.
ROA
Ibersol, S.G.P.S., S.A. generates $1.92 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Ibersol, S.G.P.S., S.A. produces operating cash flow of $146.61M, showing steady but balanced cash generation.
Free Cash Flow
Ibersol, S.G.P.S., S.A. generates strong free cash flow of $103.85M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $2.55 in free cash annually.
FCF Yield
IBS.LS converts 17.32% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
25.37
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.42
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.07
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.86
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.91
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.02
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.04
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
0.05
vs 25 benchmark
How IBS.LS Stacks Against Its Sector Peers
| Metric | IBS.LS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 25.37 | 23.78 | Neutral |
| ROE | 4.10% | 1098.00% | Weak |
| Net Margin | 2.56% | -626.00% (disorted) | Weak |
| Debt/Equity | 0.91 | 0.86 | Neutral |
| Current Ratio | 1.02 | 2.64 | Neutral |
| ROA | 1.92% | -8081.00% (disorted) | Weak |
IBS.LS outperforms its industry in 0 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Ibersol, S.G.P.S., S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-25.22%
Industry Style: Cyclical, Growth, Discretionary
DecliningEPS CAGR
-39.60%
Industry Style: Cyclical, Growth, Discretionary
DecliningFCF CAGR
-40.80%
Industry Style: Cyclical, Growth, Discretionary
Declining